Introduction of Institute of Alzheimer disease
The major research directions of the Institute of Alzheimer disease are (i) epidemiologic study on Alzheimer disease; (ii) genomics research on Alzheimer disease; (iii) peripheral biomarkers research on Alzheimer disease; (iv) neuropsychological study on Alzheimer disease; (v) neuroimaging research on Alzheimer disease; (vi) clinical trial research on Alzheimer disease; (vii) database construction and data analysis. The Institute of Alzheimer disease consists of 7 research offices, which are Alzheimer disease Epidemiological Research Office, Alzheimer disease Genomics Research Office, Alzheimer disease Peripheral Biomarkers Research Office, Alzheimer disease Neuropsychological Research Office, Alzheimer disease Neuroimaging Research Office, Alzheimer disease Clinical Trial Research Office and Database Construction and Data Analysis Office. There are 19 PIs in the Institute of Alzheimer disease.
Prof. Zhe Tang, M.D is presently Head of the General office of Beijing Geriatric Healthcare Center, and he is the Director of General Office of Division of Geriatrics of Capital Medical University.
Associate chief physician, Department of Neurology
Vice Dean of the School of Basic Medical Sciences
Director of Experiment Teaching Centre of Basic Medical Sciences (National Demonstration Centre)
Hongxing Lei, PhD, born in 1970, “100 talent” professor of Beijing Institute of Genomics, Chinese Academy of Science.
Wang Rong, researcher, Professor, PhD supervisor in neurobiology of Capital Medical University, PhD in neurobiology.
Zengqiang Yuan, Ph.D, Prof.
Principal Investigator
State Key Laboratory of Brain & Cognitive Sciences, IBP
Dr. Lan Zhang is the director of Pharmacology in Xuan-wu hospital of Capital Medical University (CMU).
Min Zhang, born in 1970, Professor, PhD advisor.
